Startups, Pharma

scPharmaceuticals’ drug/device combo aims at replacing IVs in antibiotic drug delivery

scPharmaceuticals has raised $3.6 million in what looks to be a bridge financing round for its drug/device combo that could replace IV use in treating heart failure and infections.

scpharmaceuticals

Massachusetts startup scPharmaceuticals is in the midst of a relatively small fundraise: It’s brought in $3.6 million of a proposed $7.5 million round, according to a regulatory filing.

This looks to be a bridge round for the drug/device combo startup – it closed out a $16 million Series A round in 2014, raising capital from 5AM Ventures, Gilde Healthcare Partners and Lundbeckfond Ventures.

The company is developing a new drug delivery method for both heart failure and infectious disease – developing a patch pump that can deliver medicines subcutaneously.

The company’s micropiston pump technology, engineered by Swiss devicemaker Sensile Medical, is meant to allow drugs traditionally administered via IV to be given in a constant stream with a wearable pump.

This past November, scPharmaceuticals launched a pivotal trial in which it subcutaneously administered the antibiotic ceftriaxone with its sc2Wear patch pump. It’s studying whether delivering antibiotics subcutaneously works better than with an IV.

 

Shares0
Shares0